Title:
局所エリスロポエチン製剤および前記製剤を用いて創傷治癒を改善するための方法および前記製剤の美容用途
Document Type and Number:
Japanese Patent JP7242298
Kind Code:
B2
Abstract:
Topical formulations containing erythropoietin (EPO), and also preferably fibronectin (FN), especially gel formulations, are used to accelerate wound healing, e.g., from a burn, compared to the healing process without such a formulation being applied.
Inventors:
Hermed, sahel
Application Number:
JP2018511688A
Publication Date:
March 20, 2023
Filing Date:
September 01, 2016
Export Citation:
Assignee:
Remedor Biomed Limited
International Classes:
A61K38/22; A61K8/04; A61K8/64; A61K8/65; A61K8/73; A61K9/10; A61K38/39; A61K47/10; A61K47/14; A61K47/18; A61K47/32; A61K47/36; A61K47/42; A61P3/10; A61P17/02; A61P43/00; A61Q19/00
Domestic Patent References:
| JP2010536745A | ||||
| JP2009545405A | ||||
| JP2011520985A | ||||
| JP2011507920A | ||||
| JP2006104466A | ||||
| JP11246420A |
Other References:
日本医薬品添加剤協会,医薬品添加物事典 2007,株式会社薬事日報社,2007年7月25日,pp.65,82-83,194,215-216,249
Attorney, Agent or Firm:
Patent Attorney Corporation R&C
Previous Patent: IMAGE FORMING APPARATUS, IMAGE FORMING METHOD, PROGRAM AND PRINTING SYSTEM
Next Patent: membrane assembly
Next Patent: membrane assembly